Ras mutations are uncommon in sporadic thyroid cancer in children and young adults

Journal of Endocrinological Investigation

Volumn 22, Issue 10, 1999, Pages 781-789

  Fenton, C ^a,b   Anderson, J ^a   Lukes, Y ^a   Welch Dinauer, C A ^a,b   Tuttle, R M ^a   Francis, Gary L ^a,b,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cancer; Childhood; Ras; Thyroid

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE METASTASIS; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CODON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; HYBRIDIZATION; LUNG METASTASIS; LYMPHOMA; MALE; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE RAS; POLYMERASE CHAIN REACTION; RADIATION EXPOSURE; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 0032705678     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343644     Document Type: Article

References (35)

1. Sakalidou A., Kanavaros P., Tzardi M., Kalmanti M. The expression of MYC and RAS oncogene proteins in childhood lymphomas. Anticancer Res. 1996, 16: 487-492.
2. Kalmanti M., Kalmantis Th., Vassilaki M., Galanopoulos A., Grenzelias D., Spandidos D.A. Expression of the ras p21 oncoprotein in the bone marrow smears of children with acute leukemia. Anticancer Res. 1992, 12: 2177-2180.
3. Boss J. Oncogenes in human cancer. A review. Cancer Res. 1989, 49: 4682-4689.
4. Fagin J. Genetic basis of endocrine disease 3 molecular defects in thyroid gland neoplasia. J. Clin. Endocrinol. Metab. 1992, 75: 1398-1400.
5. Suarez H.G., du Villard J.A., Severino M., Caillou B, Schlumberger M., Tubiana M., Parmentier C., Monier R. Presence of mutations in all three ras genes in human thyroid tumors. Oncogene 1990, 5: 565-570.
6. Capellá G., Matias-Guiu X., Ampudia X., de Leiva A., Perucho M., Prat J. Ras oncogene mutations in thyroid tumors: Polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues. Diagn. Mol. Pathol. 1996, 5: 45-52.
7. Hara H., Fulton N., Yashiro T., Ito K., DeGroot L. N-Ras mutation: An independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Surgery 1994, 116: 1010-1016.
8. Oyama T., Suzuki T., Hara F., Iino Y., Ishida T., Sakamoto A., Nakajima T. N-ras mutations of thyroid tumor with special reference to the follicular type. Path. Intern. 1995, 45: 45-50.
9. Ezzat S., Zheng L., Kolenda J., Safarian A., Freeman J., Asa S. Prevalence of activating ras mutations in morphologically characterized thyroid nodules. Thyroid 1996, 6: 409-416.
10. Nikiforov Y., Nikiforova M., Gnepp D., Fagin J. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene 1996, 13: 687-693.
11. Suchy B., Waldmann V., Klugbauer S., Rabes H.M. Absence of ras and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours. Br. J. Cancer 1998, 77: 952-955.
12. Challeton C., Bounacer A., Du Villar J.A., Caillou B., De Vathaire F., Monier R., Schlumberger M., Suarez H.G. Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors. Oncogene 1995, 11: 601-603.
13. Du Villard J.A., Schlumberger M., Wicker R., Caillou B., Rochefort P., Feunteun J., Monier R., Parmentier C., Suarez H.G. Role of ras and gsp oncogenes in human epithelial thyroid tumorigenesis. J. Endocrinol. Invest. 1995, 18: 124-126.
14. Wright P.A., Williams E.D., Lemoine N.R., Wynford-Thomas D. Radiation-associated and "spontaneous" human thyroid carcinomas show a different pattern of ras oncogene mutation. Oncogene 1991, 6: 471-473.
15. Schark C., Fulton N., Yashiro T., Stanislav G., Jacoby R, Straus F.H., Dytch H., Bibbo M., Kaplan E.L. The value of measurement of ras oncogenes and nuclear DNA analysis in the diagnosis of Hürthle cell tumors of the thyroid. World J. Surg. 1992, 16: 745-752.
16. Clark O.H. Predictors of thyroid tumor aggressiveness. West. J. Med. 1996, 165: 131-138.
17. Shi Y., Zou M., Schmidt H., Juhasz F., Stensky V., Robb D., Farid N. High rates of ras codon 61 mutations in thyroid tumors in an iodide-deficient area. Cancer Res. 1991, 51: 2690-2693.
18. McClellan D.R., Francis G.L. Thyroid cancer in children, pregnant women, and patients with Graves' disease. Endocrinol. Metab. Clin. North Am. 1996, 25: 27-48.
19. Buckwalter J.A., Gurll N.J., Thomas C.G. Jr. Cancer of the thyroid in youth. World J. Surg. 1981, 5: 15-25.
20. Gorlin J.B., Sallan S.E. Thyroid cancer in childhood. Endocrinol. Metab. Clin. North Am. 1990, 19: 649-662.
21. Welch-Dinauer C., Tuttle R.M., Robie D.K., McClellan D.R., Svec R.L., Adair C., Francis G.L. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin. Endocrinol. (Oxf.) 1998, 49: 619-628.
22. Martin R.K., Archer K.T., Tuttle R.M. Detection of ptc in archival formalin-fixed, paraffin-embedded tissues. Comparison of radiolabeled DNA hybridization and direct incorporation of digoxigenin-11-dUTP into RT-PCR products. Diagn. Mol. Pathol. 1995, 3: 233-239.
23. Bucsky P., Parlowsky T. Epidemiology and therapy of thyroid cancer in childhood and adolescence. Exp. Clin. Endocrinol. Diabetes 1997, 105: 70-73.
24. DeGroot L.J., Kaplan E.L., McCormick M., Straus F.H. Natural history, treatment and course of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 1990, 71: 414-424.
25. Harach H.R., Williams E.D. Childhood thyroid cancer in England and Wales. Br. J. Cancer 1995, 72: 777-783.
26. sα gene mutations in childhood thyroid tumors after Chernobyl in contrast to adult thyroid neoplasia. Cancer Res. 1997, 57: 2358-2361.
27. Mazzaferri E.L. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin. Oncol. 1987, 14: 315-332.
28. Zimmerman D., Hay I.D., Gough I.R., Goellner J.R., Ryan J.J., Grant C.S., McConahey W.M. Papillary thyroid carcinoma in children and adults: long term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 1988, 104: 1157-1166.
29. Tubiana M., Schlumberger M., Rougier P., Laplanche A., Benhamou E., Gardet P., Caillou B., Travagli J.P., Parmentier C. Long-term results and prognostic factors in patients with differentiated thyroid cancer. Cancer 1985, 55: 794-804.
30. Gilliland F.D., Hunt W.C., Morris D.M., Key C.R. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973-91. Cancer 1997, 79: 564-573.
31. Nikiforov Y., Fagin J. Radiation-induced thyroid cancer in children after the Chernobyl accident. Thyroid Today 1998, 21: 1-11.
32. Namba H., Gutman R., Matsuo K., Alvarea A., Fagin J. H-Ras protooncogene mutations in human thyroid neoplasms. J. Clin. Endocrinol. Metab. 1990, 71: 223-229.
33. Karga H., Lee J.K., Vickery A. Jr., Thor A., Gaz R., Jameson L. Ras oncogene mutations in benign and malignant thyroid neoplasms. J. Clin. Endocrinol. Metab. 1991, 73: 832-836.
34. Goretzki P., Lyons J., Stacy-Phipps S., Rosenau W., Demeure M., Clark O.H., McCormick F., Röher H.D., Bourne H.R. Mutational activation of ras and gsp oncogenes in differentiated thyroid cancer and their biological implications. World J. Surg. 1992, 16: 576-582.
35. Wright P.A., Lemoine N.R., Mayall E.S., Wyllie F.S., Hughes D., Williams E.D., Wynford-Thomas D. Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation. Br. J. Cancer 1989, 60: 576-577.